scholarly journals Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter

2020 ◽  
Vol 122 (3) ◽  
pp. 506-514
Author(s):  
Stéphane Collaud ◽  
Theresa Stork ◽  
Hans‐Ulrich Schildhaus ◽  
Christoph Pöttgen ◽  
Till Plönes ◽  
...  
2019 ◽  
Author(s):  
S Collaud ◽  
T Stork ◽  
T Plönes ◽  
K Mardanzai ◽  
D Stefani ◽  
...  

1998 ◽  
Vol 13 (11-s4) ◽  
pp. S315-S319 ◽  
Author(s):  
ZHAO-YOU TANG ◽  
XIN-DA ZHOU ◽  
ZENG-CHEN MA ◽  
ZHI-QUAN WU ◽  
JIA FAN ◽  
...  

2019 ◽  
Author(s):  
Sina Torabi ◽  
Todd Spock ◽  
Bruno Cardoso ◽  
Janet Chao ◽  
R. Manes ◽  
...  

Skull Base ◽  
2007 ◽  
Vol 17 (S 2) ◽  
Author(s):  
Sabareesh Natarajan ◽  
Laligam Sekhar ◽  
David Schessel ◽  
Akio Morita

2021 ◽  
Vol 8 (1) ◽  
pp. e000492
Author(s):  
Sarah Derby ◽  
Matthew Forshaw ◽  
Caroline Lowrie ◽  
Derek Grose ◽  
Husam Marashi ◽  
...  

BackgroundOesophageal cancer remains a common cause of cancer mortality worldwide. Increasingly, oncology centres are treating an older population and comorbidities may preclude multimodality treatment with chemoradiotherapy (CRT). We review outcomes of radical radiotherapy (RT) in an older population treating squamous cell carcinoma (SCC) oesophagus.MethodsPatients over 65 years receiving RT for SCC oesophagus between 2013 and 2016 in the West of Scotland were identified. Kaplan-Meier and Cox-regression analysis were used to compare overall survival (OS) between patients treated with radical RT and radical CRT.ResultsThere were 83 patients over 65 years treated with either RT (n=21) or CRT (n=62). There was no significant difference in median OS between CRT versus RT (26.8 months vs 28.5 months, p=0.92). All patients receiving RT completed their treatment whereas 11% of CRT patients did not complete treatment.ConclusionSurvival in this non-trial older patient group managed with CRT is comparable to that reported in previous trials. RT shows better than expected outcomes which may reflect developments in RT technique. This review supports RT as an alternative in older patients, unfit for concurrent treatment.


Author(s):  
R.A. Vadgonkar ◽  
T. Wadasadawala ◽  
S. Chakraborty ◽  
A. Budrukkar ◽  
R. Jalali ◽  
...  

Author(s):  
Marina Deuker ◽  
Marieke J. Krimphove ◽  
L. Franziska Stolzenbach ◽  
Claudia Collà Ruvolo ◽  
Luigi Nocera ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document